CLINICIAN RESOURCES
rule


A Joint Announcement from the RSS & The International Stereotactic Radiosurgery Society

We are pleased to announce that the International Stereotactic Radiosurgery Society (ISRS) and the Radiosurgery Society (RSS) entered a mutual endorsement collaboration to promote and strengthen research and educational programs dedicated to advancing the knowledge of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). As part of the agreement, each society will hold respective alternating bi-annual scientific meetings, with each society supporting and endorsing the respective meetings. Having non-competing bi-annual meetings allows each society to be more fiscally responsible with respect to the time, resources, and financial support of our members, supporters and stakeholders as well as strengthen the academic, scientific and research programs.

The societies will remain as independent organizations and will maintain separate Bylaws, Boards of Directors and membership. The partnership will help strengthen existing relationships, maximize the ability to generate and disseminate knowledge, advance science, and continue to maintain the highest standards and ensure the safety of SRS/SBRT. We look forward to working together, meeting new colleagues, and building new programs that will benefit the membership of both societies and patients receiving SRS and SBRT.

Thank you for your continued support and we look forward to seeing you at the meeting in May.

Samuel Ryu, MD - Board President, ISRS
Anand Mahadevan, MD - Board President, RSS

We've Been Published - Read the Press Release

The study titled “The RSSearch Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy” describes the design, patient demographics, lesion characteristics and SRS/SBRT treatment patterns of the first 11,457 patients enrolled in RSSearch™ from 39 participating U.S. centers was published in Radiation Oncology 2013, 8:275 (25 November 2013).


New Membership Type – Medical Residents

the RSS Board of Directors is please to announce the creation of a new category of membership. Physicians enrolled in an accredited Residency program are eligible for Medical Resident Membership. Dues for this category are $25 per year. If you are (or know) a resident who is interested in SRS/SBRT, we are confident the Radiosurgery Society provides valuable resources, contacts and knowledge to further your education.

The first step to becoming a Resident Member of the RSS is to complete the attached form and return it along with your Curriculum Vitae (CV) and a Letter of Support from your department chair. If you have additional questions, please feel free to contact us.


Patient Registry Research Tools from the RSS


ReCKord™ / RSSearch™ Patient Registry

Now that the ReCKord Patient Registry has expanded to RSSearch, improvements in the registry have been developed to include additional reporting filters. Reporting filters enable users to select specific patient cohorts when exporting their data. This allows users to expand their research capabilities, to be more efficient when conducting analyses and will provide a unique resource to support comparative effectiveness efforts for SRS/SBRT.

Other benefits of the registry include: 

  • RSSearch™ under development to include multiple treatment delivery systems
  • Track comparative utilization, treatment practices and outcomes for all SRS/SBRT platforms
  • Ready access to data for quality control, publication and collaborative research
  • Comprehensive and flexible report generation
  • Ability to easily customize database to meet individual and site needs
  • ReCKord™ will continue to exist within RSSearch™
  • Secure web-based application, both HIPAA and EU compliant
Member login  
rule
 

The RSS SRS/SBRT Scientific Meeting 2014 is endorsed by:
the American Society of Clinical Oncology® (ASCO)
the American Association of Physicists in Medicine (AAPM) and
the International Stereotactic Radiosurgery Society (ISRS).



the RSS would like to thank the following companies for their generous educational support of the meeting:

DIAMOND

Varian Medical Systems

PLATINUM

Accuray

BRONZE

Elekta

COBALT

Ashland Specialty Ingredients, G.P. - aka Gafchromic
MIM Software
Mirada Medical
Modus QA
Qfix

LEGACY

Accelitech
Alliance Oncology / US Radiosurgery
architection
Brainlab, Inc.
CIRS
CIVCO
Gold Anchor
iba Dosimetry
Integrated Medical Technologies
Orfit
PTW - New York
ScandiDos
Siemens
Standard Imaging
Sun Nuclear
View Ray
VisionRT
Xcision



This program has the American Society of Clinical Oncology’s approval for quality of educational content. ASCO endorsement does not constitute medical advice. Health care providers should exercise their own independent medical judgment. ASCO® is a registered trademark of the American Society of Clinical Oncology®. Used with permission. This is not an ASCO sponsored event.
the RSS would like to acknowledge and thank our Corporate Members.







Interact With Us!
facebook Like us on Facebook
twiter Follow us on Twitter 
Skype Me™!  Call us on Skype
Follow our Group on LinkedIn
(408) 385-9411 Give us a Call

divider